|title=TTFields / Optune Lua for Mesothelioma: STELLAR Trial, FDA Approval & Treatment Guide
...mprehensive guide to Tumor Treating Fields (TTFields) therapy using Optune Lua for malignant pleural mesothelioma. Covers STELLAR trial results (18.2-mont
...
64 KB (8,231 words) - 09:57, 6 April 2026
* '''Tumor Treating Fields Approved:''' May 2019 (Optune Lua)
| style="padding:10px; " | '''FDA approves Tumor Treating Fields (Optune Lua)'''
...
20 KB (2,490 words) - 20:57, 20 February 2026
| style="padding:10px;" | TTFields (Optune Lua)
...
14 KB (1,830 words) - 09:56, 6 April 2026
=== Tumor Treating Fields (TTFields / Optune Lua) ===
...t 150 kHz to disrupt cancer cell division. The NovoTTF-100L device (Optune Lua) was approved via Humanitarian Device Exemption in May 2019 based on the ST
...
55 KB (6,918 words) - 12:35, 6 April 2026
* '''Tumor Treating Fields:''' Optune Lua device approved 2019
* Optune Lua device
...
25 KB (3,138 words) - 20:56, 20 February 2026
| style="padding:10px;" | FDA approval of Optune Lua
* '''Tumor Treating Fields:''' Optune Lua with chemotherapy (approved May 2019)
...
38 KB (4,755 words) - 03:42, 9 March 2026
* [[TTFields Optune Lua]]
...
27 KB (3,530 words) - 04:00, 9 March 2026
...der-bottom:1px solid #dee2e6;" | '''[[TTFields_Optune_Lua|TTFields (Optune Lua)]]'''
* [[TTFields_Optune_Lua|TTFields / Optune Lua for Mesothelioma]]
...
67 KB (8,763 words) - 09:18, 6 April 2026
'''Tumor Treating Fields (TTFields):''' The Optune Lua device, approved via the FDA's Humanitarian Device Exemption pathway, deliv
* Tumor Treating Fields (TTFields/Optune Lua) combined with chemotherapy achieved median OS of 18.2 months in the single
...
59 KB (7,425 words) - 01:11, 6 April 2026
'''Tumor Treating Fields (TTFields):''' The FDA-approved Optune Lua device costs approximately $21,000 per month based on manufacturer pricing.
...
39 KB (4,954 words) - 23:00, 8 March 2026
=== Tumor Treating Fields (TTFields/Optune) ===
...inition:''' Tumor Treating Fields (TTFields), delivered through the Optune Lua device, is a novel treatment that uses low-intensity alternating electric f
...
216 KB (26,444 words) - 23:30, 23 January 2026
...herapy]], [[CAR-T Cell Therapy|CAR-T cell therapy]], and [[TTFields Optune Lua|tumor treating fields]] — will require updated protocols for managing novel
...
71 KB (9,109 words) - 09:57, 6 April 2026
* [[TTFields_Optune_Lua|TTFields / Optune Lua for Mesothelioma]]
...
66 KB (8,673 words) - 02:53, 4 March 2026
'''Tumor Treating Fields (TTFields/Optune Lua)''' remains approved only under the Humanitarian Device Exemption pathway (
...
62 KB (7,831 words) - 01:11, 6 April 2026
